Analysis and Perspectives

Feb 20, 2023

Donanemab is a promising new Alzheimer’s disease treatment. Donanemab has the potential to rule the Alzheimer’s disease market.

Feb 17, 2023

Absence of approved drugs for EBV treatment offers many opportunities for pharma companies to take advantage of an untapped EBV market.

Feb 15, 2023

Pacemakers Market is growing at an immense pace. Major development has been registered in the market. Several MedTech Companies are developing Pacemakers

Feb 13, 2023

Development of disease-specific therapies for primary biliary cholangitis treatment will auger well for market landscape in coming years.

Feb 10, 2023

Biologics are emerging as a potential option in the Nasal Polyposis Treatment Market. Several pharma companies are working in the space.

Feb 08, 2023

Technological advancements over the past few decades have significantly transformed our lives and are anticipated to exhibit the trends in the upcoming years. Our living today is simplified to a much larger extent, which seemed unrealistic to imagine over the past few years. With each passing day, technological inn...

Feb 03, 2023

Androgenetic alopecia treatment market offers a significant opportunity for several companies to investigate their lead assets. Clinical trial

Feb 01, 2023

Over the past few decades, technological innovations have led to immense growth and development in the healthcare industry and has simplified the patient treatment journey to a significant extent. The growth in high-tech medical devices, equipment, innovative targeted therapies, and ingenious procedures and techniq...

Jan 30, 2023

Leading pharma giants are currently evaluating their lead vaccine candidates for Clostridium difficile infection treatment in various stages.

Jan 27, 2023

Dynamics of lupus nephritis treatment market is expected to change in coming years as 20+ companies are exploring the therapeutics segment.